HP
Harit Pragji Shah
About Harit Pragji Shah
Data last updated:
Harit Pragji Shah is a Whole-Time Director at Aarti Drugs Limited (since 1995), Director at Pinnacle Life Science Private Limited (since 2014) and Designated Partner at Aarti Life Science Llp (since 2017), and holds 9 more current directorships. The companies operate in Chemicals and Materials, Pharma and Veterinary. The 8 current companies with reported revenue have a combined latest revenue of ₹2,745 Cr; the largest is Aarti Drugs Limited at ₹2,403 Cr (FY 2025). Earlier, Harit Pragji Shah was a Director at Anushakti Chemicals And Drugs Limited (2001–2009) and Director at Rupal Drugs Limited (2004–2009) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 15 Sep 1995 | 1984 | ₹2,403 Cr (FY 2025) | Active | |
| Director | 14 Nov 2014 | 2003 | ₹315 Cr (FY 2024) | Active | |
| Designated Partner | 16 Aug 2017 | 2012 | ₹21.70 Cr (FY 2021) | Active | |
| Director | 23 Sep 2020 | 2018 | ₹4.97 Cr (FY 2025) | Active | |
| Director | 24 Dec 2009 | 2004 | ₹34.3 Lakh (FY 2025) | Active | |
| Director | 28 Sep 2020 | 2015 | ₹3.6 Lakh (FY 2025) | Active | |
| Designated Partner | 24 Oct 2016 | 2016 | ₹51,000 (FY 2023) | Active | |
| Director | 15 Feb 2011 | 2008 | ₹5,000 (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2001 | 1992 | Amalgamated | ||
| Director | 30 Aug 2004 | 1980 | Converted To Llp | ||
| Director | 11 Oct 2010 | 1995 | ₹12.5 Lakh (FY 2025) | Active | |
| Director | 21 Feb 2004 | 2002 | Amalgamated | ||
| Director | 01 Jan 2011 | 2006 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Harit Pragji Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harit Pragji Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harit Pragji Shah
Harit Pragji Shah currently holds 12 directorships: Aarti Drugs Limited (Whole-Time Director, since 15 Sep 1995, revenue ₹2,403 Cr (FY 2025)); Pinnacle Life Science Private Limited (Director, since 14 Nov 2014, revenue ₹315 Cr (FY 2024)); Aarti Life Science Llp (Designated Partner, since 16 Aug 2017, revenue ₹21.70 Cr (FY 2021)); Panbai Welfare Foundation (Director, since 23 Sep 2020, revenue ₹4.97 Cr (FY 2025)); Radiant Gruh Private Limited (Director, since 24 Dec 2009, revenue ₹34.3 Lakh (FY 2025)); and 7 more.
Harit Pragji Shah was first appointed on 15 Sep 1995 as Whole-Time Director at Aarti Drugs Limited. The most recent appointment on record is 01 Apr 2022 at Aarti Udyog Limited Liability Partnership.
The 8 current companies of Harit Pragji Shah that report revenue have a combined latest revenue of ₹2,745 Cr: Aarti Drugs Limited ₹2,403 Cr (FY 2025); Pinnacle Life Science Private Limited ₹315 Cr (FY 2024); Aarti Life Science Llp ₹21.70 Cr (FY 2021); Panbai Welfare Foundation ₹4.97 Cr (FY 2025); Radiant Gruh Private Limited ₹34.3 Lakh (FY 2025); and 3 more.
Harit Pragji Shah held 5 earlier board appointments: Anushakti Chemicals And Drugs Limited (Director, 01 Apr 2001 to 01 Oct 2009); Rupal Drugs Limited (Director, 30 Aug 2004 to 25 Nov 2009); Aarti Corporate Services Limited (Director, 11 Oct 2010 to 25 Aug 2015); Suyash Laboratories Limited (Director, from 21 Feb 2004); Spark Pharmachem Private Limited (Director, from 01 Jan 2011).
The current boards of Harit Pragji Shah's companies include Adhish Prakash Patil (Aarti Drugs Limited), Ajit Eledath Venugopalan (Aarti Drugs Limited), Ankit Vikram Paleja (Aarti Drugs Limited), Bhaskar Narayan Thorat (Aarti Drugs Limited), Harshit Manilal Savla (Aarti Drugs Limited), Hasmukh Bhavanji Dedhia (Aarti Drugs Limited), among others.